InvestorsObserver
×
News Home

What is the Market's View on Atara Biotherapeutics Inc (ATRA) Stock's Price and Volume Trends Wednesday?

Wednesday, March 03, 2021 12:24 PM | InvestorsObserver Analysts

Mentioned in this article

What is the Market's View on Atara Biotherapeutics Inc (ATRA) Stock's Price and Volume Trends Wednesday?

The market has been down on Atara Biotherapeutics Inc (ATRA) stock recently. ATRA gets a Bearish score from InvestorsObserver's Stock Sentiment Indicator.

Sentiment Score - ,bearish
Atara Biotherapeutics Inc has a Bearish sentiment reading. Find out what this means for you and get the rest of the rankings on ATRA!

What is Stock Sentiment?

Sentiment uses short term technical analysis to gauge whether a stock is desired by investors. As a technical indicator, it focuses on recent trends as opposed to the long term health of the underlying company. Updates for the company such as a earnings release can move the stock away from current trends.

Sentiment is how investors, or the market, feels about a stock. There are lots of ways to measure sentiment. At the core, sentiment is pretty easy to understand. If a stock is going up, investors must be bullish, while if it is going down, sentiment is bearish.

InvestorsObserver’s Sentiment Indicator looks at price trends over the past week and also considers changes in volume. Increasing volume can mean a trend is getting stronger, while decreasing volume can mean a trend is nearing a conclusion.

For stocks that have options, our system also considers the balance between calls, which are often bets that the price will go up, and puts, which are frequently bets that the price will fall.

What's Happening With ATRA Stock Today?

Atara Biotherapeutics Inc (ATRA) stock is trading at $16.25 as of 12:09 PM on Wednesday, Mar 3, a decline of -$0.69, or -4.07% from the previous closing price of $16.94. The stock has traded between $16.04 and $17.19 so far today. Volume today is below average. So far 362,873 shares have traded compared to average volume of 860,664 shares.

To see the top 5 stocks in the Biotechnology industry click here.

More About Atara Biotherapeutics Inc

Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing therapeutics for patients with serious life-threatening such as cancer, autoimmune and other viral diseases. The company achieves this through two groups of product candidates, such as allogenic or third-party derived antigen-specific T-cells and molecularly targeted biologics.

Click Here to get the full Stock Score Report on Atara Biotherapeutics Inc (ATRA) Stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App